Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2016 | 08-2015 | 08-2014 | 08-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,964 | -7,232 | -5,696 | -4,232 | N/A |
| Depreciation Amortization | 4 | 4 | 6 | 5 | N/A |
| Other Working Capital | 15,043 | 862 | 161 | -353 | N/A |
| Other Operating Activity | 572 | 1,420 | 1,461 | 1,184 | 0 |
| Operating Cash Flow | $4,655 | $-4,946 | $-4,068 | $-3,396 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,275 | 14,143 | -6,574 | -4,566 | N/A |
| PPE Investments | -9 | -1 | -14 | -6 | N/A |
| Purchase Of Investment | -22,274 | -17,452 | -6,500 | N/A | N/A |
| Other Investing Activity | -2 | -2 | 0 | 3 | 0 |
| Investing Cash Flow | $-16,010 | $-3,312 | $-13,088 | $-4,569 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,043 | 9,721 | 16,640 | 5,824 | N/A |
| Financing Cash Flow | $12,043 | $9,721 | $16,640 | $5,824 | $N/A |
| Exchange Rate Effect | 6 | -12 | 6 | -18 | N/A |
| Beginning Cash Position | 3,213 | 1,762 | 2,272 | 4,431 | N/A |
| End Cash Position | 3,907 | 3,213 | 1,762 | 2,272 | N/A |
| Net Cash Flow | $694 | $1,451 | $-510 | $-2,159 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,655 | -4,946 | -4,068 | -3,396 | N/A |
| Capital Expenditure | -9 | -1 | -14 | -6 | N/A |
| Free Cash Flow | 4,646 | -4,947 | -4,082 | -3,402 | 0 |